These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 37383993)
1. Consumption of systemic antibiotics in India in 2019. Koya SF; Ganesh S; Selvaraj S; Wirtz VJ; Galea S; Rockers PC Lancet Reg Health Southeast Asia; 2022 Sep; 4():100025. PubMed ID: 37383993 [TBL] [Abstract][Full Text] [Related]
2. Injectable antibiotic use in India: public-private share in volume and cost. Fazaludeen Koya S; Ganesh S; Klemperer K; Yadav P; McDonnell A Wellcome Open Res; 2024; 9():70. PubMed ID: 39221437 [TBL] [Abstract][Full Text] [Related]
3. Threats to global antimicrobial resistance control: Centrally approved and unapproved antibiotic formulations sold in India. McGettigan P; Roderick P; Kadam A; Pollock A Br J Clin Pharmacol; 2019 Jan; 85(1):59-70. PubMed ID: 29397576 [TBL] [Abstract][Full Text] [Related]
4. Use of Fixed Dose Combination (FDC) Drugs in India: Central Regulatory Approval and Sales of FDCs Containing Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Metformin, or Psychotropic Drugs. McGettigan P; Roderick P; Mahajan R; Kadam A; Pollock AM PLoS Med; 2015 May; 12(5):e1001826; discussion e1001826. PubMed ID: 25965416 [TBL] [Abstract][Full Text] [Related]
5. Regulatory enforcement of the marketing of fixed-dose combinations in India: a case study of systemic antibiotics. Brhlikova P; Mehta A; McGettigan P; Pollock AM; Roderick P; Farooqui HH J Pharm Policy Pract; 2023 Nov; 16(1):139. PubMed ID: 37950272 [TBL] [Abstract][Full Text] [Related]
6. Fixed dose combinations of anti-tubercular, antimalarial and antiretroviral medicines on the Indian market: critical analysis of ubiquity, sales and regulatory status. Ligade VS; Thakar TM; Dengale SJ Trop Med Int Health; 2019 Feb; 24(2):238-246. PubMed ID: 30422371 [TBL] [Abstract][Full Text] [Related]
7. Systemic antibiotic sales and WHO recommendations, India. Mehta A; Brhlikova P; McGettigan P; Pollock AM; Roderick P; Farooqui HH Bull World Health Organ; 2022 Oct; 100(10):610-619. PubMed ID: 36188020 [TBL] [Abstract][Full Text] [Related]
8. Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries. Hsia Y; Sharland M; Jackson C; Wong ICK; Magrini N; Bielicki JA Lancet Infect Dis; 2019 Jan; 19(1):67-75. PubMed ID: 30522834 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Antibiotic Use in Kazakhstan for the Period 2017-2019 Based on WHO Access, Watch and Reserve Classification (AWaRe 2019). Zhussupova G; Utepova D; Orazova G; Zhaldybayeva S; Skvirskaya G; Tossekbayev K Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33430122 [TBL] [Abstract][Full Text] [Related]
10. Assessment of rationality of available fixed dose combinations of antibiotics in India. Anand P; Kaur N; Verma V; Shafiq N; Malhotra S Expert Rev Anti Infect Ther; 2022 May; 20(5):797-808. PubMed ID: 34865581 [TBL] [Abstract][Full Text] [Related]
11. High global consumption of potentially inappropriate fixed dose combination antibiotics: Analysis of data from 75 countries. Bortone B; Jackson C; Hsia Y; Bielicki J; Magrini N; Sharland M PLoS One; 2021; 16(1):e0241899. PubMed ID: 33471786 [TBL] [Abstract][Full Text] [Related]
12. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data. Klein EY; Milkowska-Shibata M; Tseng KK; Sharland M; Gandra S; Pulcini C; Laxminarayan R Lancet Infect Dis; 2021 Jan; 21(1):107-115. PubMed ID: 32717205 [TBL] [Abstract][Full Text] [Related]
13. Comparison of antibiotics included in national essential medicines lists of 138 countries using the WHO Access, Watch, Reserve (AWaRe) classification: a cross-sectional study. Adekoya I; Maraj D; Steiner L; Yaphe H; Moja L; Magrini N; Cooke G; Loeb M; Persaud N Lancet Infect Dis; 2021 Oct; 21(10):1429-1440. PubMed ID: 34332706 [TBL] [Abstract][Full Text] [Related]
14. Trends in the hospital-sector consumption of the WHO AWaRe Reserve group antibiotics in EU/EEA countries and the United Kingdom, 2010 to 2018. Benkő R; Matuz M; Pető Z; Weist K; Heuer O; Vlahović-Palčevski V; Monnet DL; Galistiani GF; Blix HS; Soós G; Hajdú E; ; Euro Surveill; 2022 Oct; 27(41):. PubMed ID: 36239173 [TBL] [Abstract][Full Text] [Related]
15. India's ban on antimicrobial fixed-dose combinations: winning the battle, losing the war? Sulis G; Pradhan R; Kotwani A; Gandra S J Pharm Policy Pract; 2022 Apr; 15(1):33. PubMed ID: 35484606 [TBL] [Abstract][Full Text] [Related]
16. Antibiotic consumption by Access, Watch and Reserve index in public sector of Limpopo province, South Africa: 2014-2018. Mthombeni TC; Burger JR; Lubbe MS; Julyan M S Afr J Infect Dis; 2022; 37(1):463. PubMed ID: 36338191 [TBL] [Abstract][Full Text] [Related]
17. Adequacy of clinical trial evidence of metformin fixed-dose combinations for the treatment of type 2 diabetes mellitus in India. Evans V; Roderick P; Pollock AM BMJ Glob Health; 2018; 3(2):e000263. PubMed ID: 29527355 [TBL] [Abstract][Full Text] [Related]
18. Community level antibiotic utilization in India and its comparison vis-à-vis European countries: Evidence from pharmaceutical sales data. Farooqui HH; Selvaraj S; Mehta A; Heymann DL PLoS One; 2018; 13(10):e0204805. PubMed ID: 30332450 [TBL] [Abstract][Full Text] [Related]
19. Antibiotic Prescribing among Pediatric Inpatients with Potential Infections in Two Private Sector Hospitals in Central India. Sharma M; Damlin A; Pathak A; Stålsby Lundborg C PLoS One; 2015; 10(11):e0142317. PubMed ID: 26540104 [TBL] [Abstract][Full Text] [Related]
20. Ten-year trends of antibiotic prescribing in surgery departments of two private sector hospitals in Central India: a prospective observational study. Skender K; Machowska A; Dhakaita SK; Lundborg CS; Sharma M BMC Public Health; 2024 Jan; 24(1):310. PubMed ID: 38281052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]